Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial"
Am J Ophthalmol
.
2022 Feb:234:329.
doi: 10.1016/j.ajo.2021.09.039.
Epub 2021 Oct 12.
Authors
Thomas W Samuelson
1
,
Inder Paul Singh
2
,
Blake K Williamson
3
,
Heather Falvey
4
,
L Jay Katz
4
,
Won Chan Lee
5
,
Dawn Odom
6
,
David McSorley
6
Affiliations
1
Minnesota Eye Consultants, Minneapolis, Minnesota, USA. Electronic address: twsamuelson@mneye.com.
2
Eye Centers of Racine and Kenosha, Wisconsin, USA.
3
Williamson Eye Center, Baton Rouge, Louisiana, USA.
4
Glaukos, San Clemente, California, USA.
5
Econforte Consulting LLC, San Francisco, California, USA.
6
RTI Health Solutions, Research Triangle Park, North Carolina, USA.
PMID:
34653356
DOI:
10.1016/j.ajo.2021.09.039
No abstract available
Publication types
Letter
Comment
MeSH terms
Cataract* / complications
Glaucoma Drainage Implants*
Glaucoma, Open-Angle*
Humans
Quality of Life